NDC 47335-050 – Doxorubicin Hydrochloride
Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · Intravenous
Product NDC47335-050
Product details
- Brand name
- Doxorubicin Hydrochloride
- Generic name
- Doxorubicin Hydrochloride
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Injectable, Liposomal
- Route
- Intravenous
- Marketing category
- ANDA · ANDA203263
- Marketed since
- February 5, 2013
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anthracycline Topoisomerase Inhibitor
Active ingredients
- Doxorubicin Hydrochloride 2 mg/mL
Uses, dosage, side effects and warnings for Doxorubicin Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 47335-050-40 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (47335-050-40) / 25 mL in 1 VIAL, SINGLE-DOSE | Feb 5, 2013 |
Recalls mentioning this NDC
- D-0229-2018 Jan 31, 2018 · Class II
Lack Of Assurance Of Sterility
Other Doxorubicin Hydrochloride products
- 45963-733 Doxorubicin Hydrochloride 2 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 62332-810 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Inc.
- 62332-525 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Inc.
- 46708-525 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Limited
- 46708-810 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Alembic Pharmaceuticals Limited
- 70121-1218 Doxorubicin Hydrochloride 2 mg/mL · Injection, Powder, Lyophilized, For Solution · Amneal Pharmaceuticals LLC
- 70121-1219 Doxorubicin Hydrochloride 2 mg/mL · Injection, Powder, Lyophilized, For Solution · Amneal Pharmaceuticals LLC
- 68001-492 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-629 Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · BluePoint Laboratories
- 68001-345 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-493 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories
- 68001-703 Doxorubicin Hydrochloride 2 mg/mL · Injectable, Liposomal · BluePoint Laboratories